Ilko K. Ilev

Ilko K. Ilev

U.S. Food and Drug Administration (FDA), USA

Expertise: biophotonics; nanobiophotonics; laser medicine; optical diagnostics and therapeutics; optical biosensing and bioimaging

Dr. Ilko Ilev has over 25 years of experience in the United States, Europe, and Japan in the field of biophotonics, nanobiophotonics, laser medicine, biomedical optics, and laser safety. He received M.S. and Ph.D. degrees in Laser Physics from Sofia University and Technical University, Bulgaria. Dr. Ilev was with the Strathclyde University, Glasgow, UK, and Institute of Physical and Chemical Research (RIKEN), Tokyo, Japan. Since 1998 he has been with the Center for Devices and Radiological Health at U.S. Food and Drug Administration (FDA) where he chairs the Optical Therapeutics and Medical Nanophotonics Laboratory. In 2012, he was appointed to the DHHS/FDA Senior Biomedical Research Service (SBRS) Scientist. Dr. Ilev is also an Adjunct Professor in the University of Maryland. He has published more than 425 papers in peer-reviewed journals and proceedings. Along with multiple original publications, he holds 12 patents. Dr. Ilev has served as Biophotonics Committee Chair of the IEEE Photonics Society and IEEE LEOS-Lasers and Electro-Optics Society. He has organized and chaired numerous international conferences on biophotonics and nanobiophotonics within the IEEE Photonics Society, Optical Society of America (OSA), International Society for Optics and Photonics (SPIE), American Society for Laser Medicine and Surgery (ASLMS), and IEEE Engineering in Medicine and Biology Society (EMBS). He serves as Primary Editor of the IEEE Journal of Selected Topics in Quantum Electronics (JSTQE) on Biophotonics and Nanobiophotonics, and on Editorial Board of Journal of Biomedical Optics (JBO) and IEEE Photonics Journal. Dr. Ilev is an elected Fellow of IEEE, OSA, SPIE, and ASLMS.